Add BrightSurf on Google Email

Next-generation immunotherapy offers new hope for beating brain cancer

Researchers at KU Leuven have developed a novel cell-based immunotherapy that combines chemotherapy, inducing specific type of cell death in brain cancer cells. This approach stimulates the immune system to attack and activate dendritic cells, resulting in a drastically increased survival rate of mice with brain tumors.

SourceKU Leuven·JournalScience Translational Medicine·DateMar 2, 2016

Using sugar to detect malignant tumors

Lund University scientists discovered that malignant tumors consume more sugar than surrounding tissue, making sugar a promising non-synthetic contrast agent. The study's results suggest the potential to reduce medical care costs by replacing metal-based agents with sugar-based alternatives.

SourceLund University·JournalTomography·DateFeb 22, 2016

Study finds significant cognitive impairment in adult survivors of childhood brain tumors

Researchers at St. Jude Children's Research Hospital found that adult survivors of childhood brain tumors exhibit significant cognitive deficits in intelligence, educational achievement, and employment. The study also showed that hydrocephalus is associated with poor cognitive function, even decades after treatment.

SourceSt. Jude Children's Research Hospital·JournalJournal of Clinical Oncology·DateFeb 1, 2016

Brain tumor revealed by treatment-resistant depression

A woman with treatment-resistant depression was found to have a brain tumor after symptoms persisted for six months despite antidepressant and anti-anxiety medication. The tumor, located in her left frontal lobe, was later treated successfully with emergency surgery, resulting in the disappearance of depressive symptoms.

SourceBMJ Group·JournalBMJ Case Reports·DateDec 22, 2015

'Smart fat cells' cross blood-brain barrier to catch early brain tumors

Researchers at Penn State College of Medicine have developed a new nanotechnology approach using 'smart fat cells' that can pass the blood-brain barrier to detect early-stage brain tumors. This breakthrough could transform gliomas from a death sentence into a treatable condition, enabling patients to receive timely treatment.

SourcePenn State·JournalJournal of NeuroInterventional Surgery·DateDec 17, 2015

Signaling pathway suppresses brain tumors

A recent study published in Cancer Cell found that a key signaling pathway present in most organisms actually suppresses the formation of specific types of brain tumor, including gliomas. This discovery has significant implications for glioma treatment and diagnosis.

SourceUniversity of Basel·JournalCancer Cell·DateDec 4, 2015

Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor

Researchers at Massachusetts General Hospital have reported the first successful use of a targeted therapy drug to treat a patient with a debilitating, recurrent brain tumor. Treatment with BRAF inhibitor dabrafinib led to rapid shrinkage of the tumor, and the patient remains symptom-free over a year after treatment.

SourceMassachusetts General Hospital·JournalJNCI Journal of the National Cancer Institute·DateNov 6, 2015

Chemotherapy-induced hearing loss affects cognition in pediatric brain tumor survivors

A new study reveals that chemotherapy-induced hearing loss in pediatric brain tumor survivors can lead to significant neurocognitive deficits, including intelligence, executive function, and verbal reasoning skills. Children who received radiation therapy and developed hearing loss are at particularly high-risk for these deficits.

SourceChildren's Hospital Los Angeles·JournalPediatric Blood & Cancer·DateNov 3, 2015

Laser-based imaging tool could increase accuracy, safety of brain tumor surgery

Researchers are testing a stimulated Raman scattering microscope to image brain tissue in real-time, allowing surgeons to see the difference between tumor tissue and normal brain. The technology has the potential to resolve a long-standing issue in cancer surgery by providing faster and more effective methods to assess tumor removal.

SourceMichigan Medicine - University of Michigan·JournalScience Translational Medicine·DateOct 15, 2015

Medical diagnosis: Will brain palpation soon be possible?

Inserm researchers have developed a noninvasive brain imaging method using MRI that provides the same information as physical palpation, allowing for early diagnosis of brain tumors or Alzheimer's disease. The technique uses noise correlation to detect natural shear waves in the brain, enabling building images of the brain's elasticity.

SourceINSERM (Institut national de la santé et de la recherche médicale)·JournalProceedings of the National Academy of Sciences·DateOct 7, 2015

Complete resection of high-grade brain cancer yields better survival in children -- especially girls

A study published in Neurosurgery found that complete resection of high-grade brain cancer significantly improves survival rates in children. The study revealed a greater survival benefit for female patients compared to male patients. Gross total resection (GTR) improved the chances of survival free of recurrent or progressive cancer o...

SourceWolters Kluwer Health·JournalNeurosurgery·DateAug 18, 2015

Nutrients turn on key tumor signaling molecule, fueling resistance to cancer therapy, Ludwig Cancer Research study shows

Researchers found that glucose and acetate can activate key tumor signaling molecule mTORC2, allowing tumors to resist targeted therapies like EGFR inhibitors. This discovery provides a potential window into treating glioblastoma, a deadly brain cancer with limited treatment options.

SourceLudwig Institute for Cancer Research·JournalProceedings of the National Academy of Sciences·DateJul 13, 2015

Scientists find way to disrupt brain tumor stem cells

Researchers at Washington University School of Medicine identified a key player in maintaining brain tumor stem cells' ability to survive and replenish themselves. Disrupting this process using protein CDC20 has been shown to reduce tumor growth by up to 95 percent in mice, offering new hope for treating glioblastoma.

SourceWashU Medicine·JournalCell Reports·DateJun 11, 2015

Study discovers new method of classifying low-grade brain tumors

A new classification system has been developed to improve the diagnosis and treatment of low- and intermediate-grade gliomas (LGGs), reducing the reliance on subjective tumor appearance. The system uses molecular and genetic analysis to identify three distinct groups of LGGs with varying prognoses, offering a more objective approach.

SourceUniversity Hospitals Cleveland Medical Center·JournalNew England Journal of Medicine·DateJun 10, 2015